Lonza Group stock forecast
Lonza Group (LO3A) Stock Forecast & Price Target
LO3A Analyst Ratings
LO3A Stock 12 Month Forecast
Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Berenberg Bank | €76.59→€71.74 | buy | 1.05%Upside | Assigned | 04/15/26 | |||
| Charles Weston | RBC Capital | ― | buy | ― | Upgraded | 02/11/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| BuyAssigned€76.59→€71.74 | 04/15/26 | 1.05%Upside | |||
| Charles WestonRBC Capital | BuyUpgraded | 02/11/26 | ― |
Best Analysts Covering Lonza Group
Copying PerPlexity Biotechnology's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +7.00% per trade.
Copying Charles Weston's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +24.00% per trade.
Copying Charles Weston's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +24.00% per trade.
LO3A Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, LO3A has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. LO3A average Analyst price target in the past 3 months is ―.
LO3A Financial Forecast
LO3A Earnings Forecast
Next quarter’s earnings estimate for LO3A is EUR 1.00 with a range of EUR 0.95 to EUR 1.03. The previous quarter’s EPS was EUR 0.89. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
LO3A Sales Forecast
Next quarter’s sales forecast for LO3A is EUR 4.01B with a range of EUR 3.90B to EUR 4.07B. The previous quarter’s sales results were EUR 3.81B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

